News & Events

Check out our news section to keep up to date with any upcoming events which we will be attending as well as any exciting news within the pharmaceutical industry.

Symbiosis secures FDA viral vector process approval

Stirling, UK – SYMBIOSIS Pharmaceutical Services, a fast-growing specialist sterile manufacturing CDMO, has reported FDA approval for its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK.Symbiosis recently hosted a successful inspection by the United States Government Food and Drug Administration (FDA) for the aseptic manufacture of viral vector products for commercial supply into the U.S market… Read More

Cobra Biologics and Symbiosis awarded £1.9m ($2.5m USD) Innovate UK Grant

Keele and Stirling, UK, 1 February 2018: Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, and Symbiosis Pharmaceutical Services (Symbiosis), a contract manufacturing organisation (CMO) specialising in sterile Fill Finish, today announced that they have been awarded a 16-month collaborative grant of £1.9m from Innovate UK.The grant will position the partner companies as globally recognised… Read More

Colin Mackay, CEO of Symbiosis

Steady growth in 2017 points to a successful year ahead for Symbiosis

Another year has passed here at Symbiosis HQ and I’m pleased to report that 2017 has been another strong year of sustained, profitable, growth for the company.Our underlying positive growth trend has continued, and aligns well with our strategic focus on developing the business in the North American market alongside our more established client base in Europe. Our efforts to proactively build… Read More

Cover story: Scottish Specialty CMO Thrives as ‘One-Stop-Shop’ Becomes the Trend

We were recently invited to feature in Pharmaceutical Processing’s Apri/May edition with a cover story on how Symbiosis Pharmaceutical Services has thrived as a small-scale, niche sterile manufacturer depsite the ‘one-stop-shop’ model becoming the trend.Throughout the article, Colin Mackay outlines how our facility in Stirling, Scotland has addressed specific gaps in the sterile drug product manufacturing marketplace. He also addresses not only our… Read More

Roundtable: Aseptic Manufacturing Trends

CEO of Symbiosis Pharmaceutical Services, Colin Mackay, was recently invited to participate in a roundtable discussion on aseptic manufacturing trends for Contract Pharma along with leaders from Recipharm and ChargePoint Technology.The resulting article explores key trends and challenges when it comes to aseptic manufacturing.In the article, Colin explains: “The development of robust single-use manufacturing technology has been a step-change in the sector, enabling more efficient… Read More

Scottish CMO opens US office

Symbiosis Pharmaceutical Services is set to open an office in North America in response to continued demand from US-based biotechnology companies for its vial-filling expertise.The sterile filling specialist will open a commercial site in Cambridge, Boston, MA, to support its clients on both the East and West Coast, as well as giving the contract manufacturing organisation (CMO) a base for reaching new customers… Read More

Colin Mackay, CEO of Symbiosis

A positive end to a positive year at Symbiosis

It may feel like only yesterday we were planning for 2016, but here we are at the end of another successful year. While the last 12 months have seemingly gone in a flash, it’s been another encouraging year at Symbiosis Pharmaceutical Services.With the support of our clients, staff, suppliers and partners, I’m pleased to say it’s been another steady year of growth… Read More

The Good CMO Guide – What should small biotechs look for when outsourcing clinical trial manufacturing?

What kind of relationship are you looking for? It’s the first question that should be on the minds of biotech companies once the decision to outsource clinical trial manufacturing of parenterals to a CMO has been made. Is it a transactional relationship? One where a service is sourced and swiftly delivered without much in the way of long-term planning or on-going work… Read More

Q&A: Parenteral Outsourcing Trends

Our own Colin MacKay, CEO of Symbiosis Pharmaceutical Services, was recently invited to participate in a roundtable discussion assessing the trends driving parenteral manufacturing for an article for Contract Pharma.The resulting article explores the trends that are fuelling the demand for parenteral manufacturing, the changing structure of the CMO industry and the impact on biotech and small pharma companies needing to outsource… Read More

Q&A: Biotech growth driving ‘surge in demand’

Here at Symbiosis Pharmaceutical Services we’re preparing for increasing growth in the outsourcing sector following an investment at our sterile filling facility and the appointment of Dr. Tom Scullion, US Business Development Manager.Having joined the team to support increased demand for our sterile filling services from biotechs, Tom was recently invited to talk about his role here at Symbiosis and his insight into where… Read More

Get In Touch